Brown et al. demonstrated the safety of up to 12 adjuvant infusions of IL13Rα2-directed CAR-T cells into the cavity in three patients with recurrent GBM at a maximum dose of 108 cells [45]. Here, IL13RA2 is linked to glioblastoma.